bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung
Go back to bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung| (NASDAQ: BIAF) | Delayed: 0.81 +0.01 (1.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.80 | 52 Week High | $ | |||
| Open | $0.80 | 52 Week Low | $ | |||
| Day High | $0.83 | P/E | N/A | |||
| Day Low | $0.80 | EPS | $ | |||
| Volume | 217,563 | |||||
| (NASDAQ: BIAFW) | Delayed: 0.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.14 | 52 Week High | $ | |||
| Open | $0.09 | 52 Week Low | $ | |||
| Day High | $0.14 | P/E | N/A | |||
| Day Low | $0.09 | EPS | $ | |||
| Volume | 6,008 | |||||

